A study of the clinical outcome of patients with profound mental retardation gradually withdrawn from chronic neuroleptic medication

Ann Clin Psychiatry. 1995 Dec;7(4):155-60. doi: 10.3109/10401239509149620.

Abstract

In a naturalistic study of 23 severely and profoundly mentally retarded adult male patients undergoing slow "diagnostic" neuroleptic taper, it was determined that at least 60% could eventually be managed without psychoactive medication. However, many of these demonstrated a remarkably long, but nonetheless transient, period of worsening. This suggests that behavioral deterioration during drug reduction trials does not always indicate a need for chronic neuroleptic maintenance since these behaviors may return to baseline without pharmacological intervention. On the other hand, 40% demonstrated persistent (> 2 years) behavioral worsening. Those individuals who demonstrated persistent deterioration had been generally well controlled on neuroleptics, were somewhat older, and were receiving a higher baseline dose. Most of these persistently worsened subjects currently require some type of psychoactive medication (although only two have been returned to neuroleptics).

MeSH terms

  • Adult
  • Antipsychotic Agents / administration & dosage*
  • Antipsychotic Agents / adverse effects
  • Antipsychotic Agents / therapeutic use
  • Diagnosis, Differential
  • Dose-Response Relationship, Drug
  • Epilepsy / diagnosis
  • Epilepsy / etiology
  • Humans
  • Intellectual Disability / complications*
  • Intellectual Disability / psychology
  • Male
  • Mental Disorders / chemically induced
  • Mental Disorders / drug therapy*
  • Middle Aged
  • Substance Withdrawal Syndrome / diagnosis
  • Substance Withdrawal Syndrome / etiology
  • Thioridazine / administration & dosage*
  • Thioridazine / adverse effects
  • Thioridazine / therapeutic use
  • Treatment Outcome

Substances

  • Antipsychotic Agents
  • Thioridazine